Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12928)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2016 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dietrich CG, Götze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016; 22(1): 72-88 [PMID: PMC4698509 DOI: 10.3748/wjg.v22.i1.72] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/72.htm |
| Number | Citing Articles |
| 1 |
Matthew D. Harwood, Amin Rostami‐Hodjegan, Sibylle Neuhoff. Drug Transporters. 2022; : 475 doi: 10.1002/9781119739883.ch23
|
| 2 |
Mohamed Bouattour, Eric Raymond, Shukui Qin, Ann‐Lii Cheng, Uz Stammberger, Giuseppe Locatelli, Sandrine Faivre. Recent developments of c‐Met as a therapeutic target in hepatocellular carcinoma. Hepatology 2018; 67(3): 1132 doi: 10.1002/hep.29496
|
| 3 |
Vamshi Jogiraju, Elijah Weber, Jason Hindman, Steve West, John Ling, Martin Rhee, Sandhya Girish, Ramesh Palaparthy, Renu Singh, Miguel Angel Martinez. Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment. Antimicrobial Agents and Chemotherapy 2024; 68(4) doi: 10.1128/aac.01344-23
|
| 4 |
Sara Armani, Andreas Geier, Thomas Forst, Uta Merle, David H. Alpers, Martin W. Lunnon. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions. British Journal of Clinical Pharmacology 2024; 90(4): 942 doi: 10.1111/bcp.15990
|
| 5 |
Sarah Musa Hammoudeh, Arabella Musa Hammoudeh, Poorna Manasa Bhamidimarri, Bassam Mahboub, Rabih Halwani, Qutayba Hamid, Mohamed Rahmani, Rifat Hamoudi. Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World Journal of Gastroenterology 2021; 27(21): 2850-2870 doi: 10.3748/wjg.v27.i21.2850
|
| 6 |
Fan Wang, Ming-xing Miao, Bin-bin Sun, Zhong-jian Wang, Xian-ge Tang, Yang Chen, Kai-jing Zhao, Xiao-dong Liu, Li Liu. Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp. Acta Pharmacologica Sinica 2017; 38(11): 1554 doi: 10.1038/aps.2017.54
|
| 7 |
Eloïne Bestion, Zuzana Macek Jilkova, Jean-Louis Mège, Marie Novello, Keerthi Kurma, Seyedeh Tayebeh Ahmad Pour, Gilles Lalmanach, Lise Vanderlynden, Lionel Fizanne, Firas Bassissi, Madani Rachid, Jennifer Tracz, Jérôme Boursier, Jérôme Courcambeck, Cindy Serdjebi, Christelle Ansaldi, Thomas Decaens, Philippe Halfon, Sonia Brun. GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-β1 inhibition. Therapeutic Advances in Chronic Disease 2020; 11 doi: 10.1177/2040622320942042
|
| 8 |
Brian M. Fung, Deanna J. Leon, Lauren N. Beck, James H. Tabibian. Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease. Digestive Diseases and Sciences 2022; 67(7): 2739 doi: 10.1007/s10620-021-07111-1
|
| 9 |
Jong Hwan Sung. Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs. Expert Opinion on Drug Metabolism & Toxicology 2021; 17(8): 969 doi: 10.1080/17425255.2021.1908996
|
| 10 |
Ruo Fan Sheng, He Qing Wang, Li Yang, Kai Pu Jin, Yan Hong Xie, Cai Xia Fu, Meng Su Zeng. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance. Digestive and Liver Disease 2017; 49(7): 789 doi: 10.1016/j.dld.2017.02.006
|
| 11 |
Jordan J. Haworth, Charlotte K. Pitcher, Giuseppe Ferrandino, Anthony R. Hobson, Kirk L. Pappan, Jonathan L. D. Lawson. Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath. Critical Reviews in Clinical Laboratory Sciences 2022; 59(5): 353 doi: 10.1080/10408363.2022.2038075
|
| 12 |
Madhura Joshi, Suma Uday. Vitamin D Deficiency in Chronic Childhood Disorders: Importance of Screening and Prevention. Nutrients 2023; 15(12): 2805 doi: 10.3390/nu15122805
|
| 13 |
Giuseppe Ferrandino, Federico Ricciardi, Antonio Murgia, Iris Banda, Menisha Manhota, Yusuf Ahmed, Kelly Sweeney, Louise Nicholson-Scott, Lucinda McConville, Olga Gandelman, Max Allsworth, Billy Boyle, Agnieszka Smolinska, Carmen A. Ginesta Frings, Jorge Contreras, Claudia Asenjo-Lobos, Viviana Barrientos, Nataly Clavo, Angela Novoa, Amy Riviotta, Melissa Jerez, Luis Méndez. Exogenous Volatile Organic Compound (EVOC®) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis and Reveals Signs of Portal Hypertension. Biomedicines 2023; 11(11): 2957 doi: 10.3390/biomedicines11112957
|
| 14 |
Hyunsuk Yoo, Jeong Min Lee, Jeong Hee Yoon, Hyo-Jin Kang, Sang Min Lee, Hyun Kyung Yang, Joon Koo Han. T2* Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment?. Korean Journal of Radiology 2017; 18(4): 682 doi: 10.3348/kjr.2017.18.4.682
|
| 15 |
Christoph G. Dietrich, Andreas Geier. What is the impact of metabolic dysfunction–associated steatotic liver disease on drug transport and metabolism?. Expert Opinion on Drug Metabolism & Toxicology 2024; 20(3): 107 doi: 10.1080/17425255.2024.2324015
|
| 16 |
Noora Sjöstedt, Sibylle Neuhoff, Kim L.R. Brouwer. Physiologically‐Based Pharmacokinetic Model of Morphine and Morphine‐3‐Glucuronide in Nonalcoholic Steatohepatitis. Clinical Pharmacology & Therapeutics 2021; 109(3): 676 doi: 10.1002/cpt.2037
|
| 17 |
Giovanni Tarantino, Mauro Cataldi, Vincenzo Citro. Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?. International Journal of Molecular Sciences 2022; 23(18): 10406 doi: 10.3390/ijms231810406
|
| 18 |
Junzhen Wu, Xinyi Yang, Jufang Wu, Jingjing Wang, Hailan Wu, Yu Wang, Hong Yuan, Huahui Yang, Hailin Wang, Jing Zhang. Dose adjustment not required for contezolid in patients with moderate hepatic impairment based on pharmacokinetic/pharmacodynamic analysis. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1135007
|
| 19 |
Sergio Salgüero, David Rojo, Juan Berenguer, Juan González‐García, Amanda Fernández‐Rodríguez, Oscar Brochado‐Kith, Cristina Díez, Victor Hontañon, Ana Virseda‐Berdices, Javier Martínez, Luis Ibañez‐Samaniego, Elba Llop‐Herrera, Coral Barbas, Salvador Resino, María A. Jiménez‐Sousa. Plasma metabolomic fingerprint of advanced cirrhosis stages among HIV/HCV‐coinfected and HCV‐monoinfected patients. Liver International 2020; 40(9): 2215 doi: 10.1111/liv.14580
|
| 20 |
Yingjie Ai, Xiaoquan Huang, Wei Chen, Ling Wu, Siyu Jiang, Ying Chen, Shiyao Chen. UPLC-MS/MS-Based Serum Metabolomics Signature as Biomarkers of Esophagogastric Variceal Bleeding in Patients With Cirrhosis. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.839781
|
| 21 |
Abdulrahman Ismaiel, Vera Ciornolutchii, Thelva Esposito Herrera, Mohamed Ismaiel, Daniel‐Corneliu Leucuta, Stefan‐Lucian Popa, Dan L. Dumitrascu. Adiponectin as a biomarker in liver cirrhosis—A systematic review and meta‐analysis. European Journal of Clinical Investigation 2025; 55(1) doi: 10.1111/eci.14328
|
| 22 |
Baheti Kalifu, Yuan Meng, Zhi-Gang Ma, Chao Ma, Guang-Lei Tian, Jin-Guo Wang, Xiong Chen. Silencing circ-RNA-049637 influences hydatid outer cyst wall formation by liver fibrosis. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00345-4
|
| 23 |
Giuseppe Ferrandino, Isabel Orf, Rob Smith, Marzia Calcagno, Anita Kaur Thind, Irene Debiram-Beecham, Megan Williams, Olga Gandelman, Alexandra de Saedeleer, Graham Kibble, Anne Marie Lydon, Chris A. Mayhew, Max Allsworth, Billy Boyle, Marc P. van der Schee, Michael Allison, Matthew Hoare, Victoria K. Snowdon. Breath Biopsy Assessment of Liver Disease Using an Exogenous Volatile Organic Compound—Toward Improved Detection of Liver Impairment. Clinical and Translational Gastroenterology 2020; 11(9): e00239 doi: 10.14309/ctg.0000000000000239
|
| 24 |
Wei Meng, Tao Chen. Association between the HGF/c‑MET signaling pathway and tumorigenesis, progression and prognosis of hepatocellular carcinoma (Review). Oncology Reports 2021; 46(3) doi: 10.3892/or.2021.8142
|
| 25 |
Hongli Zhang, Qingqing Feng, Wei-Dong Chen, Yan-Dong Wang. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers. International Journal of Molecular Sciences 2018; 19(11): 3295 doi: 10.3390/ijms19113295
|
| 26 |
Bianca Sulzbacher da Silva, Angélica Macedo Borgês Paulino, Maiara Taffarel, Ian Gabriel Borba, Luciana Ortega Telles, Victor Vitorino Lima, Danilo Henrique Aguiar, Marcos Correa Dias, André Ferreira Nascimento, Valéria Dornelles Gindri Sinhorin, Renata de Azevedo Melo Luvizotto, Gisele Facholi Bomfim. High sucrose diet attenuates oxidative stress, inflammation and liver injury in thioacetamide-induced liver cirrhosis. Life Sciences 2021; 267: 118944 doi: 10.1016/j.lfs.2020.118944
|
| 27 |
Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulations. 2021; : 417 doi: 10.1002/9781119497813.ch16
|
| 28 |
Zubia Jamil, Sharmin Arif, Anum Khan, Asghar Aurangzeb Durrani, Nayyar Yaqoob. Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00055
|
| 29 |
Jutta Keller, Heinz F. Hammer, Paul R. Afolabi, Marc Benninga, Osvaldo Borrelli, Enrique Dominguez‐Munoz, Dan Dumitrascu, Oliver Goetze, Stephan L. Haas, Bruno Hauser, Daniel Pohl, Silvia Salvatore, Marc Sonyi, Nikhil Thapar, Kristin Verbeke, Mark R. Fox. European guideline on indications, performance and clinical impact of 13C‐breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC. United European Gastroenterology Journal 2021; 9(5): 598 doi: 10.1002/ueg2.12099
|
| 30 |
Marc Ruoß, Silas Rebholz, Marina Weimer, Carl Grom-Baumgarten, Kiriaki Athanasopulu, Ralf Kemkemer, Hanno Käß, Sabrina Ehnert, Andreas K. Nussler. Development of Scaffolds with Adjusted Stiffness for Mimicking Disease-Related Alterations of Liver Rigidity. Journal of Functional Biomaterials 2020; 11(1): 17 doi: 10.3390/jfb11010017
|
| 31 |
William S. Baldwin. Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors As a First Step in Protection from Xenobiotics. Nuclear Receptor Research 2019; 6 doi: 10.32527/2019/101447
|
| 32 |
Amandine Verlande, Sung Kook Chun, Wei A. Song, Daniela Oettler, Harm J. Knot, Selma Masri. Exogenous detection of 13C-glucose metabolism in tumor and diet-induced obesity models. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.1023614
|
| 33 |
Chang-gue Son. A Case of Hepatotoxicity by Salvia Plebeia R. Br.. The Journal of Internal Korean Medicine 2019; 40(6): 1219 doi: 10.22246/jikm.2019.40.6.1219
|
| 34 |
Eman El-Khateeb, Brahim Achour, Zubida M. Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan. Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment. Molecular Pharmaceutics 2021; 18(9): 3563 doi: 10.1021/acs.molpharmaceut.1c00462
|
| 35 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
|